Top Markets
Coin of the day
Pangaea Oncology, S.A. Pangaea Oncology, S.A.

Pangaea Oncology, S.A.

PANG
株式のランク #24020
Pangaea Oncology, S.A. delivers essential medical services to cancer patients... Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
株価
$1.84
最終同期: 2026-08-21
時価総額
$66.03M
変化(1日)
0.00%
変化(1年)
-8.25%
ES
取引 Pangaea Oncology, S.A. (PANG)

カテゴリー

Pangaea Oncology, S.A.(PANG)の発行済株式数
August 2026 時点の発行済株式数 0
Pangaea Oncology, S.A. の最新の財務報告および株価によると、現在の発行済株式数は 0 です。August 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Pangaea Oncology, S.A.(PANG)の発行済株式数の履歴(2026 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社の発行済株式数
企業 発行済株式数
371.00M -
US
705.30M -
US
- -
CN
143.28M -
US
283.00M -
US